| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 09/26/2002 | US20020137699 Expression systems comprising chimeric promoters with binding sites for recombinant transcription factors |
| 09/26/2002 | US20020137207 Cultured cells of Rhapiolepis umbellata thunb. and a method for culturing tissues of the Rhapiolepis umbellata thunb. by using said cultured cells |
| 09/26/2002 | US20020137204 Conditioned medium collected from a culture of feeder cells with laminin or collagen |
| 09/26/2002 | US20020137190 High growth methanotrophic bacterial strain |
| 09/26/2002 | US20020137182 For obtaining and using a polypeptide other than oncogene BCL-2 that affects programmed vertebrate cell death |
| 09/26/2002 | US20020137155 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher Basidiomycetes mushroom |
| 09/26/2002 | US20020137152 Fermentation process for epothilones |
| 09/26/2002 | US20020137151 Process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding for the sod gene |
| 09/26/2002 | US20020137150 Culture product containiong corynebacterium |
| 09/26/2002 | US20020137145 Human erythropoietin gene: high level expression in stably transfected mammalian cells |
| 09/26/2002 | US20020137140 Fermentation method for production of heterologous gene products in lactic acid bacteria |
| 09/26/2002 | US20020137133 Receptor proteins |
| 09/26/2002 | US20020137115 Cgmp- visualizing probe and a method of detecting and quantifying of cgmp by using the same |
| 09/26/2002 | US20020137095 Reelin protein CR-50 epitope region |
| 09/26/2002 | US20020137094 Method for improving thermostability of proteins, proteins having thermostability improved by the method and nucleic acids encoding the proteins |
| 09/26/2002 | US20020137091 Labeling with fluorescent dyes; forming libraries |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020136741 Extracting with a polyoxyethylene detergent to deplete inner membranes, extracting remaining outer membranes with zwitterionic betaine dertergent to separate lipooligosaccharides from insoluble factions used for vaccines |
| 09/26/2002 | US20020136736 Or prophylactically or therapeutically effective fragment thereof in admixture with a pharmaceutically acceptable carrier |
| 09/26/2002 | US20020136730 From coagulase-negative bacteria produced in substantially pure form; use of purified adhesin product as vaccine for production of antibodies effective against binding of homologous bacterial cells to polymeric materials |
| 09/26/2002 | CA2441915A1 Thermophilic microorganism bacillus coagulans strain sim-t dsm 14043 for the production of l(+)-lactate from fermentable sugars and their mixtures |
| 09/26/2002 | CA2441275A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
| 09/25/2002 | EP1243596A2 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase and methods for identification of inhibitors thereof |
| 09/25/2002 | EP1243256A1 Vaccines absorbable by the transmucosal way |
| 09/25/2002 | EP1242612A1 Method for continuous cultivation of microorganisms of the genus eremothecium |
| 09/25/2002 | EP1242601A1 Trichoderma reesei xylanase |
| 09/25/2002 | EP1242437A2 Novel stromelysin inhibitors |
| 09/25/2002 | EP0696320B1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 09/25/2002 | EP0652966B1 Method of increasing expression of viral proteins |
| 09/25/2002 | CN1371426A Process for preparatino of derivatives of ruscus aculeatus steroid glycosides by enzymatic hydrolysis |
| 09/25/2002 | CN1371420A Orynebacterium glutamicum genes encoding phosphoenolpyruvate sugar phosphotransferase system proteins |
| 09/25/2002 | CN1371379A New indolocarbazole alkaloids from marine actinomycete |
| 09/25/2002 | CN1370836A Fermentation process of preparing O-acetyl-L-serine |
| 09/25/2002 | CN1091447C 4,7-dialkoxy-N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses inclinical specimens |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455504 Pesticidal macrolides |
| 09/24/2002 | US6455323 Contacting virulence protein with chemical compound, then identifying compounds which bind or interacts with protein; for bactericides against staphylococcus aureus |
| 09/24/2002 | US6455314 Recombinant fiber protein having a trimerization domain and which interacts with adenoviral penton base; for gene transfer methods |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455289 Amino acid sequence of enzyme; for preparation of ligands of l-selectin |
| 09/24/2002 | US6455288 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
| 09/24/2002 | US6455284 Escherichia coli cell transformed with polynucleotide which codes for pyruvate carboxylase; for increased production of succinate and threonine |
| 09/24/2002 | US6455279 Culturing prokaryotic cells transformed with expression vector encoding the polypeptide with a signal sequence and expression vector encoding chaperone protein found in prokaryotes, then cleaving off the signal sequence |
| 09/24/2002 | US6455247 Introducing library of randomized nucleic acids linked to secretion signal into cells, expressing nucleic acids to form peptides, and screening second cells which are co-cultured with first cells for altered phenotypes |
| 09/24/2002 | US6455050 Human administration comprising a protective, highly-immunogenic, non-immunopotentiating copurified mixture of hn and f glycoproteins of human parainfluenza type 3 prepared by copurification from native piv-3 virus by affinity |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | CA2210769C Detection of bacteria of genus listeria using nucleic probe hybridisation techniques |
| 09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
| 09/24/2002 | CA1341388C Hybrid pesticidal toxins |
| 09/23/2002 | CA2378494A1 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 09/19/2002 | WO2002072856A2 Improved process for converting nitriles to carboxylic acids using nitrilase |
| 09/19/2002 | WO2002072843A1 Novel vectors for animal cells and utilization thereof |
| 09/19/2002 | WO2002072841A1 Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid |
| 09/19/2002 | WO2002072110A1 Caloporoside derivatives, methods for the production thereof and their use |
| 09/19/2002 | WO2002050119A3 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 09/19/2002 | US20020133836 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/19/2002 | US20020132775 Human potassium channel 1 and 2 proteins |
| 09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 09/19/2002 | US20020132337 Processes for preparation of marek's disease virus using continuous avian cell lines |
| 09/19/2002 | US20020132334 Nucleotide sequences coding preferential polypeptide for use in the treatment of tumors and nervous system disorders |
| 09/19/2002 | US20020132311 Converting glycerol to 1,3-propanediol in thermophilic microorganisms; obtain microorganismal culture, incubate with glycerol, recover 1,3-propanediol |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020131983 Method for inducing an immunological response in a host by administering to the host at least one antigen and a lipoprotein |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | US20020131940 Carotenoid preparation |
| 09/19/2002 | DE10112401A1 Alkohol-Dehydrogenase und deren Verwendung Alcohol dehydrogenase and the use thereof |
| 09/19/2002 | CA2432190A1 Improved process for converting nitriles to carboxylic acids using nitrilase |
| 09/18/2002 | EP1241263A1 Alcohol dehydrogenase and uses therefor |
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/18/2002 | EP1241248A1 Method of proliferating a microorganism capable of degrading a hard-to-degrade organic compound and use thereof |
| 09/18/2002 | EP1240348A1 Method for preparing conjugated linoleic acid |
| 09/18/2002 | EP1240323A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/18/2002 | EP1240310A2 Method of inactivating microorganisms |
| 09/18/2002 | EP1240194A2 Novel human protein kinases and protein kinase-like enzymes |
| 09/18/2002 | EP1240192A2 Attenuated microorganisms for the treatment of infection |
| 09/18/2002 | EP0789763B1 Icam-4 materials and methods |
| 09/18/2002 | EP0764217B1 Use of a specific marker for detecting Salmonella with PCR |
| 09/18/2002 | EP0648263B1 Lipases from hyphozyma |
| 09/18/2002 | EP0592582B1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 09/18/2002 | EP0575357B1 Human follicle stimulating hormone receptor |
| 09/18/2002 | CN1370242A Genomic profiling: repid method for testing complex biological sample for presence of many types of organisms |
| 09/18/2002 | CN1370239A Streptomyces avermitilis gene directing ratio of B2:B1 avermectins |
| 09/18/2002 | CN1370233A ERS-genes, method of screening for chemical compounds capable of inducing ERS in plants |
| 09/18/2002 | CN1370232A Methods for making APO-2 ligand using divalent metal ions |
| 09/18/2002 | CN1370227A Bacterial consortium EBC1000 and method using bacterial consortium EBC 1000 for remedying biologically recalcitrant toxic chemicals contained in industrial wastewater etc. |
| 09/17/2002 | US6451997 Kits for detecting chromosomal rearrangements |
| 09/17/2002 | US6451982 Polypeptide with amino acid sequences grafted into human heavy and light chain variable regions |
| 09/17/2002 | US6451769 Compositions and methods for administering Borrelia DNA |
| 09/17/2002 | US6451764 VEGF-related protein |
| 09/17/2002 | US6451760 Treatment of inflammation using a 2F1 polypeptide or an antibody thereto |
| 09/17/2002 | US6451595 Murine leukemia virus with pol, env, and gag coding regions deleted; gene therapy; gene expression and engineering |
| 09/17/2002 | US6451582 Staphylococcus strains comprising an inducible gene encoding an RNA polymerase specificity factor |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | US6451565 Method of producing γ-decalactone using Yarrowia lipolytica strain HR 145 (DSM 12397) |
| 09/17/2002 | US6451561 Growth hormone variants |